Researchers sought to determine the relationship among hospitalization for COPD exacerbation, AF burden, and risk for subsequent stroke.

GLP-1 use significantly lowered risk for atrial fibrillation-related events for patients with diabetes, AF and obesity, with ...

Average and brisk walking paces were associated with significantly lower risks for all cardiac arrhythmias, atrial fibrillation, and other arrhythmias compared with slow walking paces. HealthDay News ...

SGLT2 inhibitors, compared with GLP1 agonists, significantly lower risk for atrial fibrillation in patients with type 2 diabetes.

Abbott has reported new data from its prospective, non-randomised Volt CE Mark Study, indicating that individuals treated ...

One-year clinical trial data for the next-generation, investigational, Sphere-360™ single-shot PFA catheter show impressive safety, performance, and efficiency results for paroxysmal AfibDual-energy ...

Accounting for mortality as competing risk, the Afib burden trended numerically in favor of the GLP-1 RA group (HR 0.85, 95% ...

Research indicates that brisk walking offers significant benefits beyond weight loss, notably enhancing longevity and heart ...

‘Training on synthetic fibrosis images achieved a 0.943 ROC-AUC—nearly matching real MRI data (0.952). AI is transforming heart treatment.#aiinhealthcare #medindia ’ Existing methods like ...

A recently completed clinical study investigated whether a toilet seat equipped with ECG sensors can reliably detect atrial fibrillation. The “Hamberger Heart Study” was conducted at the ...

In patients with AF, abelacimab, compared with rivaroxaban, is associated with decreased bleeding across multiple bleeding risk categories. Abelacimab is associated with reduced bleeding compared ...